An overview of the current market dynamics for high containment manufacturing from the perspective of HPAPI manufacturing decision-makers at sponsor organizations at small and midsize biopharmaceutical companies and their predictions on what the market will look like in five years.

This report provides an overview of the current market dynamics for high containment manufacturing as well as an outlook on what some HPAPI manufacturing decision-makers at sponsor organizations predict the marketplace will look like five years from now.

Outsourcing decision-makers for cell or gene therapies at sponsor organizations give an overview of the current market dynamics in the cell & gene therapies contract manufacturing space and predictions through 2026.

This report explores which delivery formats drug innovators are using in their pipelines and portfolios, how likely innovators are to outsource manufacturing based on delivery device, and how these proportions will shift over the next five years.

This market research report provides an overview of the current market dynamics in the oral dose contract manufacturing space as well as an outlook of what our survey respondents—all oral dose outsourcing decision-makers at sponsor organizations—predict the marketplace will look like in 2024. Key statistics include oral dose project volume, percentage outsourced, and the average number of CMOs used to...

This report provides an overview of the current market dynamics in the clinical manufacturing space as well as an outlook of what our survey respondents predict the marketplace will look like in 2022.

This market research report offers readers the opportunity to gain insight into the biopharmaceutical excipient market and where it’s heading. Remaining aware of market dynamics and expected changes will enable readers to better make key decisions regarding excipient use and to help identify where competitive advantages may be gained.

This report explores how the decision-making process differs among drug innovators outsourcing development activities from those outsourcing commercial manufacturing when it comes to CMO/CDMO selection criteria, use patterns, preferences and perceived leadership.

This market research report explores how the decision-making process differs among drug innovators outsourcing development activities from those outsourcing commercial manufacturing when it comes to CMO/CDMO selection criteria, use patterns, preferences and perceived leadership.

This report will help biopharma companies make more informed CDMO decisions, and will help CDMOs optimize operational and marketing strategies.

This report offers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 22 performance attributes.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality.

This report has been designed to help biopharmaceutical companies make more informed CMO decisions, and to help CMOs optimize operational and marketing strategies.

This report is based on responses from 45 people involved in outsourced large molecule API projects over the last 18 months. It will help new/emerging pharma companies make informed CDMO selections, and help CDMOs better understand how they are perceived.

This market research report explores how sponsor organizations use contract manufacturers to streamline costs, better manage capacity, access scientific expertise, improve efficiencies and decrease time to market.

ISR conducted five in-depth interviews and 31 online surveys with experienced market researchers in the biopharmaceutical space to gain a better grasp on the market research function. Research subjects shared their insights on the types of research performed, how their market research function is structured, and outsourcing behavior.

ISR interviewed 15 CMC professionals at 14 Top 50 pharmaceutical and biotechnology companies, as well as one company outside the Top 50 to better understand the Chemistry Manufacturing and Controls function throughout the preclinical, clinical, and commercialization phases of the product development process.

This market research report has been designed to be used as a benchmarking tool for companies to compare their Medical Science Liaison functions to those of other pharmaceutical and biotech organizations. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within...